One such mechanism that has thus far been described involves the aryl hydrocarbon receptor (AHR), which is a ligand-activated transcription factor expressed both in NK cell developmental intermediates (NKDI) as well as AML blasts [20]. This evidence concerns the gene AHR and acute myeloid leukemia.